Journal of Critical Care Added to Library Collection

The MSK Library has recently added the Journal of Critical Care to our library’s collection.  As the official publication of the World Federation of Societies of Intensive and Critical Care Medicine (WFSICCM), the Journal of Critical Care is a leading international, peer-reviewed journal providing original research, review articles, and tutorials for physicians and allied health professionals involved in treating the critically ill. The Journal aims to improve patient care by furthering understanding of health systems research and its integration into clinical practice.

Those interested in submitting a paper for publication must first register on the Journal’s site.  The Journal of Critical Care can be accessed in our Journal A-Z listing or in TriCat, the library catalog.

Use Single Citation Matcher to Find the Article You Need

When trying to find a particular article, it is often helpful to use PubMed’s Single Citation Matcher. Enter the citation information that you have (Journal, Date, Volume, First page, Author, etc.) in the appropriate fields, and it will narrow your search to help you find the article you need. The more information you input, the more likely you are to retrieve just the one article you are seeking. If you only have part of the citation information, however, you can still input the information and then search among the results to find your article.

If you have any questions about using this PubMed feature, don’t hesitate to contact Reference at 212-639-7439 or asklibrarian@mskcc.org.

Increased PSA Screening for Prostate Cancer Reduces Mortality and more…

  • The results of a study conducted by Umeå University in Sweden and MSK, have suggested that the greater the number of PSA tests for prostate cancer carried out in a geographic area, the lower the prostate cancer mortality in that area.  The increase in testing needs to be followed by early treatment to achieve these results.  There is controversy regarding increased PSA screening because it leads to overtreatment.
  • Investigators Jedd Wolchok and Dmitriy Zamarin of MSK collaborated with MD Anderson Cancer Center researchers to study synergism between oncolytic virotherapy and cancer immunotherapy to increase the immune response against cancerous tumors.  The researchers combined cancer immunotherapy and the Newcastle disease virus (NDV), a virus that initiates an immune response.  The results have been promising. Continue reading